ctrl K

TScan Therapeutics Inc. (TCRX)

NASDAQ: TCRX · Real-Time Price · USD

1.60

0.05 (3.23%)

At close: May 02, 2025, 3:59 PM

1.55

-3.11%

After-hours: May 02, 2025, 04:29 PM EDT

TScan Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	2.82M	21.05M	13.54M	10.14M	1.08M	n/a
Cost of Revenue	n/a	88.15M	5.14M	3.33M	20.58M	519K
Gross Profit	2.82M	-67.1M	8.4M	6.81M	-19.49M	-519K
Operating Income	-134.82M	-93.46M	-66.64M	-48.64M	-26.23M	-14.21M
Interest Income	12.06M	8M	1.59M	16K	106K	552K
Pretax Income	-127.5M	-89.22M	-66.22M	-48.63M	-26.13M	-13.66M
Net Income	-127.5M	-89.22M	-65.81M	-48.63M	-26.02M	-13.11M
Selling & General & Admin	29.56M	26.35M	20.35M	13.83M	6.74M	4.77M
Research & Development	107.35M	88.15M	59.82M	44.95M	20.58M	9.44M
Other Expenses	n/a	n/a	1.59M	16K	n/a	n/a
Operating Expenses	137.64M	114.51M	80.17M	58.78M	27.32M	14.21M
Interest Expense	3.65M	3.76M	1.18M	n/a	n/a	n/a
Selling & Marketing Expenses	-728K	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	137.64M	114.51M	80.17M	58.78M	27.32M	14.21M
Income Tax Expense	n/a	n/a	-415K	3.09M	-106K	-552K
Shares Outstanding (Basic)	111.99M	65.6M	24.05M	23.91M	24.94M	24.94M
Shares Outstanding (Diluted)	111.99M	65.6M	24.05M	23.91M	24.94M	24.94M
EPS (Basic)	-1.14	-1.36	-2.74	-2.03	-1.04	-0.53
EPS (Diluted)	-1.14	-1.36	-2.74	-2.03	-1.04	-0.53
EBITDA	-119.74M	-80.1M	-59.91M	-45.3M	-25M	-13.69M
EBIT	-123.85M	-85.46M	-65.05M	-48.63M	-26.23M	-14.21M
Depreciation & Amortization	4.11M	5.36M	5.14M	3.33M	1.23M	519K